Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Begemann

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Molecular Psychiatry|April 7, 2021
Preadult polytoxicomania-strong environmental underpinnings and first genetic hintsAgnes A Steixner-Kumar, Vinicius Daguano Gastaldi, Jan Seidel, et al.
The Lancet. Psychiatry|September 12, 2015
Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based studyBeata Stepniak, Sergi Papiol, Christian Hammer, et al.
Journal of Neuro-Oncology|August 2, 2003
Primary leptomeningeal primitive neuroectodermal tumorMartin Begemann, David Lyden, Marc K Rosenblum, et al.
Molecular Medicine (Cambridge, Mass.)|September 27, 2021
Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analoguesMartin Begemann, Oliver Gross, Dominik Wincewicz, et al.
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
BMC Psychiatry|May 14, 2015
Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophreniaAnne Kästner, Martin Begemann, Tanja Maria Michel, et al.
EMBO Molecular Medicine|June 18, 2017
A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptomsKatarzyna Lepeta, Katarzyna J Purzycka, Katarzyna Pachulska-Wieczorek, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 15, 2011
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophreniaSergi Papiol, Martin Begemann, Albert Rosenberger, et al.
Archives of General Psychiatry|August 4, 2011
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor systemKatja Ribbe, Verena Ackermann, Judith Schwitulla, et al.
American Journal of Human Genetics|October 13, 2015
Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common VirusesChristian Hammer, Martin Begemann, Paul J McLaren, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Molecular Psychiatry|April 7, 2021
Preadult polytoxicomania-strong environmental underpinnings and first genetic hintsAgnes A Steixner-Kumar, Vinicius Daguano Gastaldi, Jan Seidel, et al.
The Lancet. Psychiatry|September 12, 2015
Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based studyBeata Stepniak, Sergi Papiol, Christian Hammer, et al.
Journal of Neuro-Oncology|August 2, 2003
Primary leptomeningeal primitive neuroectodermal tumorMartin Begemann, David Lyden, Marc K Rosenblum, et al.
Molecular Medicine (Cambridge, Mass.)|September 27, 2021
Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analoguesMartin Begemann, Oliver Gross, Dominik Wincewicz, et al.
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
BMC Psychiatry|May 14, 2015
Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophreniaAnne Kästner, Martin Begemann, Tanja Maria Michel, et al.
EMBO Molecular Medicine|June 18, 2017
A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptomsKatarzyna Lepeta, Katarzyna J Purzycka, Katarzyna Pachulska-Wieczorek, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 15, 2011
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophreniaSergi Papiol, Martin Begemann, Albert Rosenberger, et al.
Archives of General Psychiatry|August 4, 2011
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor systemKatja Ribbe, Verena Ackermann, Judith Schwitulla, et al.
American Journal of Human Genetics|October 13, 2015
Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common VirusesChristian Hammer, Martin Begemann, Paul J McLaren, et al.
Pageof 4